Follow RT on In a major breakthrough for Russia’s Sputnik V Covid-19 vaccine, the prestigious British medical journal The Lancet has published preliminary Phase III trial results showing it is highly effective – notably, for all age groups.
Data from 19,866 volunteers – 4,902 of whom were in the placebo group – showed that Sputnik V had an overall efficacy of 91.6 percent, rising to 91.8 percent among the group of 2,144 volunteers over the age of 60, according to the interim results of the Phase III clinical trial published in the Lancet on Tuesday.
At the end of the study, there were 62 confirmed Covid-19 cases in the placebo group and only 16 in the vaccine group. Sputnik V proved to be 100 percent effective in preventing the development of severe cases.
To improve the performance of our website, show the most relevant news products and targeted advertising, we collect technical impersonal information about you, including through the tools of our partners. You can find a detailed description of how we use your data in our Privacy Policy. For a detailed description of the technologies, please see the Cookie and Automatic Logging Policy.
By clicking on the Accept & Close button, you provide your explicit consent to the processing of your data to achieve the above goal.
You can withdraw your consent using the method specified in the Privacy Policy.
Accept & Close
Sputnik International
Others pointed out the contrast between Trump’s decision to pardon the Blackwater US military contractors convicted of killing civilians in Iraq and “shady political operatives”, but not Assange and Snowden, who many observers view as icons of press freedom.
Snowden, 37, fled the US after leaking secret National Security Agency files in 2013 and was given asylum in Russia. In November he announced that he would seek Russian citizenship together with his wife for the sake of their family; the couple are expecting a baby.
US authorities have for years wanted Snowden returned to face a criminal trial on espionage charges.